Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 384 of 673

Advanced search

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Keros expects to distribute 25% of net cash proceeds after Takeda payment

stocktitan.netOriginal source

🌍Jul 31Industryenanta.comTier 1 · Company source

SARS-CoV-2 Resistance Pathways to EDP-235

Enanta PharmaceuticalsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Millions of eye drops recalled. See list of affected products

USA TodayOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Euro Roundup: EFPIA pushes for shorter trial approval times in EU Biotech Act

RAPSOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Insilico Medicine to Present AI-Designed Drug for Mesothelioma Treatment, FDA to Fast-Track

Mesothelioma GuideOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA raids: Hospitality bodies oppose premature public naming, welcome hygiene crackdown

Mid-DayOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Aardvark shares plunge 32% after FDA halts clin...

pluang.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Mexico’s pharmaceutical and healthcare sectors under scrutiny as regulators zero in on cartel conduct

Global Competition ReviewOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

EU regulatory roundup: AbbVie, Pfizer & BioNTech and Incyte net approvals

Pharmaceutical TechnologyOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Inizio Engage launches Connected Insights | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months

StocktwitsOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia

BioSpaceOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

How biotech steadies beauty’s ingredient supply chain challenges

Personal Care InsightsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Weekly Oral Islatravir-Lenacapavir Noninferior to Daily HIV Therapy in Phase 3 Trial

Medical DialoguesOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Hospitality bodies urge Maharashtra FDA to avoid naming eateries before due process

The Times of IndiaOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Aardvark Therapeutics (AARD) Scrutinized Again After FDA Hold on Lead Drug Candidate, May Announcement Drives Stock 32% Lower - Hagens Berman

PR NewswireOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Why Collaboration is Key in Biotech

BioPharm InternationalOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech's Sac-TMT Gains NMPA Review for First-Line Advanced TNBC Indication

BioPharm InternationalOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

EyePoint stock could surge over 200% as Mizuho names biotech company its top small cap pick

Business UpturnOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Gilead’s Twice-Yearly HIV Strategy: What the New Phase 3 Study Means for Investors

tipranks.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical companies in talks with NICE about access to Alzheimer’s drugs

The Pharmaceutical JournalOriginal source

🌍Jul 31discoverynews.google.comTier 2 · Trade media

J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B

BioPharma DiveOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Botulinum Toxin Wins First FDA Clearance to Test Frown-Muscle Theory of Depression

Tech TimesOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

FDA’s Advisory Committee Votes on Peptides: What It Does and Doesn’t Do | Mintz - Health Care Viewpoints

JD SupraOriginal source

🇯🇵Jul 30Industrynippon-shinyaku.co.jpTier 1 · Company source

Tadekinig alfaの米国におけるオプション権行使のお知らせ

Nippon Shinyaku NewsOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator says

reuters.comOriginal source

🇺🇰Jul 30Researchmft.nhs.ukTier 2 · Direct publisher

Stem cell transplant recipient completes 1,000-mile bike ride after lifesaving care at Manchester Royal Infirmary

Manchester University NHS Foundation TrustOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Pharma Pulse: Infinitus' AI Hub Play, EVERSANA's Cell Therapy Partnership, Cold Chain Deals

Pharmaceutical CommerceOriginal source

🇯🇵Jul 30Researchriken.jpTier 2 · Direct publisher

Team Director Uta Paszkowski Elected Fellow of the Royal Society

RIKENOriginal source

🌍Jul 30discoverynews.google.comTier 2 · Trade media

BMS CEO Boerner doesn’t ‘feel any compulsion to chase deals’ despite lack of M&A this year

Fierce BiotechOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

China’s Fermentation Giants Turn to Mycoprotein as Pharma Margins Shrink

Cultivated XOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Raised to $19.13, Implies 8% Upside

TradingViewOriginal source

🌍Jul 30Mediaheartsciences.comTier 2 · Direct publisher

Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem

HeartSciencesOriginal source

🌍Jul 30discoverynews.google.comTier 2 · Trade media

Australia approves first-in-class Niktimvo for later-line cGVHD

Pharmaceutical TechnologyOriginal source

🌍Jul 30discoverynews.google.comTier 2 · Trade media

FDA AdCom shuns Capricor’s DMD cell therapy amid data dispute

Pharmaceutical TechnologyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

National partnership agreement on asylum seeker health in England

A national partnership agreement on meeting the health and wellbeing needs for people seeking asylum...

UK Health Security AgencyOriginal source

🌍Jul 30Industryorthofix.comTier 1 · Company source

Surgeon-Led Bone Biologics Education for Spinal Fusion

OrthofixOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Maharashtra CM Devendra Fadnavis launches 'Drug-Free Mumbai' campaign

Mid-DayOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE

marketscreener.comOriginal source

🌍Jul 30discoverynews.google.comTier 2 · Trade media

GSK, AI biotech Relation pen $110M biological datasets pact

Fierce BiotechOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Pharmacy Inside Jobs : sports pharmacist

The Pharmaceutical JournalOriginal source

🇮🇹Jul 30Industryrecordati.comTier 1 · Company source

RECORDATI: PUBLICATION OF THE INTERIM REPORT FIRST HALF (AS AT 30.06.2026)

RecordatiOriginal source

🌍Jul 30discoverynews.google.comTier 2 · Trade media

Boston Scientific cuts guidance again after unveiling restructuring plan

Fierce BiotechOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Ember, Alfresa Strike Japan Cold Chain Alliance

Pharmaceutical CommerceOriginal source

🌍Jul 30Associationasn-online.orgTier 2 · Direct publisher

BRCU Online 2026 Now Available

American Society of NephrologyOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Regulations Are Being Implemented: FDA Commissioner Tukaram Munde On Statewide Food Safety Drive - VIDEO

freepressjournal.inOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Ember LifeSciences wins Alfresa backing for Japan cold chain push

The Pharma LetterOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

NHS and industry join forces on next generation of hospitals

NHS trusts and construction partners have signed agreements to deliver the next phase of the New Hos...

UK Department of Health and Social CareOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Cingulate publishes phase 3 ADHD drug trial results in journal

Investing.comOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer

manilatimes.netOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

What's Next for Direct-to-Patient?

Pharmaceutical CommerceOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance reports: 2025 to 2026 season

National influenza (flu) and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other s...

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

National measles guidelines

How to manage cases of suspected measles: what patient details to take, who to notify and assessing...

UK Health Security AgencyOriginal source

🌍Jul 30discoverynews.google.comTier 2 · Trade media

Attovia, Braveheart and Vogenx seek more than $500M across trio of IPOs

Fierce BiotechOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Will Generic Drug Tariffs Impact Pharma ETFs?

TradingViewOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

HK restates support for cell and gene therapy amid biotech push

chinadailyasia.comOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology

The Manila TimesOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

The Biotech Growth Trust PLC - Net Asset Value(s)

Yahoo Finance UKOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

IN PHOTOS: Sudents in Maharashtra may soon see healthier school menus

Mid-DayOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

India takes action against 90 pct of inspected high-risk pharmaceutical facilities

mediaselangor.comOriginal source